Fox Businessยท2025-04-29 15:20Core Insights - Hims & Hers Health has announced a collaboration with Novo Nordisk to bundle the weight-loss drug Wegovy with its telehealth membership, providing 24/7 care, clinical support, and nutrition guidance [1][5] - The partnership aims to enhance consumer-centered healthcare and is seen as a significant step towards achieving that vision, as stated by Hims & Hers CEO Andrew Dudum [2] - Following the announcement, shares of Hims & Hers surged by 25% [2] Pricing and Availability - The bundled service will have a starting price of $599 per month [4] - Wegovy will be available in all dosage strengths through Hims & Hers' platform, which will also include access to Novo Nordisk's NovoCare Pharmacy for cash-paying patients [4][5] Future Developments - Hims & Hers and Novo Nordisk are working on a roadmap to integrate innovative treatments with the telehealth platform's capabilities to scale access to quality care [7] - Other telehealth companies, such as Ro and Life MD, have also announced partnerships with Novo Nordisk to offer Wegovy and integrate NovoCare Pharmacy into their platforms [9] Market Context - Wegovy is part of a popular class of GLP-1 medications for weight loss, alongside Novo's Ozempic and Eli Lilly's Zepbound and Mounjaro [10]